Inventor
WELLS KENNETH M
US18 patents
⚠️ This page may combine multiple inventors who share the name “WELLS KENNETH M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
11 patentsUS6407241B1Jun 18, 2002
Process and intermediates for the preparation of imidazolidinone αv integrin antagonists
MERCK & CO INC19 citations82
US7074930B2Jul 11, 2006
Amine salts of an integrin receptor antagonist
MERCK & CO INC10 citations73
US5618939AApr 8, 1997
Process for making HIV protease inhibitors
MERCK & CO INC4 citations73
US5919937AJul 6, 1999
Process for phosphodiesterase IV inhibitors
MERCK & CO INC16 citations72
US5637711AJun 10, 1997
Process for making HIV protease inhibitors
MERCK & CO INC3 citations62
US5922906AJul 13, 1999
Side chains synthesis for an anthiarrhythmic compound
MERCK & CO INC2 citations61
US6346617B1Feb 12, 2002
Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof
MERCK & CO INC3 citations60
US6194568B1Feb 27, 2001
Process for synthesizing carbapenem intermediates
MERCK & CO INC0 citations51
US5861512AJan 19, 1999
Process for making HIV protese inhibitors
MERCK & CO INC0 citations51
US5693803ADec 2, 1997
Process for making HIV protease inhibitors
MERCK & CO INC0 citations51
US5777123AJul 7, 1998
Process for regioselective substitution of trifluorobenzoate or trifluorobenzonitrile
MERCK & CO INC0 citations50
JANSSEN PHARMACEUTICA NV
3 patentsUS7951829B2May 31, 2011
Benzimidazole modulators of VR1
JANSSEN PHARMACEUTICA NV6 citations60
US9434711B2Sep 6, 2016
Sulfonamides as TRPM8 modulators
JANSSEN PHARMACEUTICA NV0 citations49
US8835417B2Sep 16, 2014
Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone
JANSSEN PHARMACEUTICA NV0 citations47